Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 8
Submit an article Journal homepage
371
Views
8
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis

Zeina Al-MansourCardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL, USA; Correspondence[email protected]
View further author information
,
Hongli LiSWOG Statistical Center, Seattle, WA, USA; View further author information
,
James R. CookCleveland Clinic, Cleveland, OH, USA; View further author information
,
Louis S. ConstineUniversity of Rochester, Rochester, NY, USA; View further author information
,
Stephen CoubanQueen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Canada; View further author information
,
Douglas A. StewartTom Baker Cancer Centre, University of Calgary, Calgary, Canada; View further author information
,
Thomas C. SheaUniversity of North Carolina, Chapel Hill, NC, USA; View further author information
,
Pierluigi PorcuSidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA; View further author information
,
Jane N. WinterNorthwestern University, Chicago, IL, USA; View further author information
,
Brad S. KahlUniversity of Wisconsin, Madison, WI, USA; View further author information
,
Sonali M. SmithUniversity of Chicago, Chicago, IL, USA; View further author information
,
Deborah C. MarcellusJuravinski Hospital and Cancer Centre, Hamilton, Canada; View further author information
,
Kevin P. BartonCardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL, USA; View further author information
,
Glenn M. MillsLouisiana State University Health Sciences Center, Shreveport, LA, USA; View further author information
,
Michael LeBlancSWOG Statistical Center, Seattle, WA, USA; View further author information
,
Lisa M. RimszaMayo Clinic, Scottsdale, AZ, USA; View further author information
,
Stephen J. FormanCity of Hope Medical Center, Duarte, CA, USA; View further author information
,
John P. LeonardWeill Cornell Medicine, New York, NY, USA; View further author information
,
Richard I. FisherTemple University School of Medicine, Fox Chase Cancer Center – Temple Health, Philadelphia, PA, USAView further author information
,
Jonathan W. FriedbergUniversity of Rochester, Rochester, NY, USA; View further author information
&
Patrick J. StiffCardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL, USA; View further author information
 show all
Pages 1934-1941 | Received 26 Jun 2018, Accepted 20 Dec 2018, Published online: 10 Jan 2019

References

  • Vose J, Armitage J, Weisenburger D. International T-Cell Lymphoma Project. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124–4130.
  • Schmitz N, Trümper L, Ziepert M, et al. Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group. Blood. 2010;116:3418–3425.
  • Sonnen R, Schmidt WP, Müller-Hermelink HK, et al. The International Prognostic Index determines the outcome of patients with nodal mature T-cell lymphomas. Br J Haematol. 2005;129:366–372.
  • Nademanee A, Palmer JM, Popplewell L, et al. High -dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factors. Biol Blood Marrow Transplant. 2011;17:1481–1489.
  • Corradini P, Tarella C, Zallio F, et al. Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia. 2006;20:1533–1538.
  • Mercadal S, Briones J, Xicoy B, et al. Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma. Ann Oncol. 2008;19:958–963.
  • Rodríguez J, Conde E, Gutiérrez A, et al. Frontline autologous stem cell transplantation in high-risk peripheral T-cell lymphoma: a prospective study from The Gel-Tamo Study Group. Eur J Haematol. 2007;79:32–38.
  • Reimer P, Rüdiger T, Geissinger E, et al. Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study. J Clin Oncol. 2009;27:106–113.
  • Wilhelm M, Smetak M, Reimer P, et al. First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation. Blood Cancer J. 2016;6:e452.
  • Jantunen E, D’Amore F. Stem cell transplantation for peripheral T-cell lymphomas. Leuk Lymphoma. 2004;45:441–446.
  • Smith S, Burns LJ, van Beisen K, et al. Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma. J Clin Oncol. 2013;31:3100–3109.
  • Philip T, Guglielmi C, Hagenbeek A, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma. N Engl J Med. 1995;333:1540–1545.
  • Stiff P. What is the role of autologous transplant for lymphoma in the current era. Hematology Am Soc Hematol Educ Program. 2015;2015:74–81.
  • Stiff PJ, Unger JM, Cook JR, et al. Autologous transplantation as consolidation for aggressive non-Hodgkin’s lymphoma. N Engl J Med. 2013;369:1681–1690.
  • Vose J, Armitage J, Weisenburger D. International peripheral T-Cell and natural killer/T-cell lymphoma study: pathology and clinical outcomes. J Clin Oncol. 2008;26:4124–4130.
  • Casulo C, O’Connor O, Shustov A, et al. T-cell lymphoma: recent advances in characterization and new opportunities for treatment. J Natl Cancer Inst. 2017;109:djw248.
  • Moskowitz AJ, Lunning MA, Horwitz SM. How I treat the peripheral T-cell lymphomas. Blood. 2014;123:2636–2644.
  • d’Amore F, Relander T, Lauritzsen GF, et al. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. J Clin Oncol. 2012;30:3093–3099.
  • Savage KJ, Harris NL, Vose JM, et al. ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK + ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood. 2008;111:5496–5504.
  • Ellin F, Landström J, Jerkeman M, et al. Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry. Blood. 2014;124:1570–1577.
  • Lunning MA, Horwitz S. Treatment of peripheral T-cell lymphoma: are we data driven or driving the data? Curr Treat Options Oncol. 2013;14:212–223.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.